Skip to content

Clinical trials

Inflammatory Breast Neoplasms trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Breast Neoplasms Phase: Not applicable Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20071
20141
20181
20191
20201
20211
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Recruiting3
Active, not recruiting2
Not yet recruiting1
Terminated1
Completed1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
Auxilio Mutuo Cancer Center1
Brigham and Women's Hospital1
Clayton State University1
Dana-Farber Cancer Institute1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
National Cancer Institute (NCI)1
Royal Marsden NHS Foundation Trust1
Scott and White Hospital & Clinic1
The University of Tennessee, Knoxville1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Breast Neoplasms13
Breast Neoplasms10
Breast Carcinoma In Situ2
Triple Negative Breast Neoplasms2
Agnosia1
Cancer Pain1
Carcinoma, Lobular1
Fatigue1
Hot Flashes1
Melanoma1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.